Clinical Trials Logo

Filter by:
NCT ID: NCT05075850 Completed - Cognitive Change Clinical Trials

Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection

Start date: September 29, 2021
Phase:
Study type: Observational [Patient Registry]

PatiEnt Neuropsychological outcomeS After laseR ablation

NCT ID: NCT05075733 Completed - Clinical trials for Scope of Practice of Today's Hepatopancreatobiliary Surgeons

Current Scope of Practice of Today's Hepatopancreatobiliary Surgeons: A Survey of AHPBA Members

Start date: December 1, 2014
Phase:
Study type: Observational

The development of multiple training pathways to foster competent hepatopancreatobiliary (HPB) surgeons has led to a diverse group of surgical subspecialists. The objective of our study was to determine the current scope of practice of today's HPB surgeons. An online survey was sent to all the Americas Hepato-Pancreato-Biliary Association's members to assess the current scope of practice of today's HPB surgeons. We found very few surgeons run a solo HPB practice, so changes may be needed in HPB training to provide uniformity and enhance the scope of practice for future HPB surgeons.

NCT ID: NCT05075408 Completed - Clinical trials for Chronic Kidney Disease Associated Moderate to Severe Pruritus

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

NemoCKDaP
Start date: December 29, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of nemolizumab compared to placebo at reducing the intensity of pruritus after a 12-week treatment period in adult hemodialysis participants with moderate to severe pruritus.

NCT ID: NCT05075395 Completed - Critical Illness Clinical Trials

Animal Assisted Interactions With Animal Robot During PT/OT in the ICU

PARO
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to: 1. Establish the feasibility and acceptability of a therapeutic robot, Paro, for critically ill patients admitted to the Pediatric Intensive Care Unit 2. Explore safety considerations related to infection control [participant hospital-acquired infection (HAI) rates, screening for the presence of microbial contamination with real-time ATP testing 3. Examine the therapeutic effect of Paro on patient psychological variables, physiological variables, and sedative and analgesic medication requirements.

NCT ID: NCT05075330 Completed - Opioid-use Disorder Clinical Trials

SMART Trial: Community Stigma Reduction

Start date: June 16, 2021
Phase: N/A
Study type: Interventional

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

NCT ID: NCT05075278 Completed - Anesthesia Clinical Trials

Supervision Models in Training Environments

VSI
Start date: July 7, 2021
Phase: N/A
Study type: Interventional

Attending physicians often supervise novice junior residents in a direct one-to-one format. Alternatively, a senior resident can be paired with a new trainee under the non-direct (but immediately available) supervision of an attending physician. Resident supervision has been considered an important step towards independent practice. Both models are ubiquitous in the United States, but no study to date has been performed if one model is better than the other with respect to supervision scores.

NCT ID: NCT05074875 Completed - Covid19 Clinical Trials

COVID-19 Respiratory Outcomes Registry

Start date: January 15, 2021
Phase:
Study type: Observational

This is a 48-week, observational study looking to see if the inflammatory process of hypoxemic respiratory failure associated with COVID-19 leads to progressive pulmonary fibrosis. Inpatient, as well as outpatient adults with recent COVID-19 hospitalization will be recruited. Data from hospitalization will be collected and subjects will return to the center for follow-up visits. Subjects will undergo the following procedures: High Resolution Computed Tomography (HRCT) of the chest, Pulmonary Function Tests (PFT), Muscle Strength Measurement, and blood draw for biomolecular data such as biomarkers found in ribonucleic acid (RNA), deoxyribonucleic acid (DNA), serum, and plasma. Quality of Life (QoL) measurements will also be collected through the study.

NCT ID: NCT05074719 Completed - COVID-19 Clinical Trials

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)

IICov19PRS
Start date: December 10, 2020
Phase:
Study type: Observational

Clinical trials of prevention modalities for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and coronavirus disease (COVID-19) and pneumonia are underway under separate protocol(s) for close contacts (i.e., household contacts, [e.g.,3502]) of infectious (index) individuals (3502-01). Characterizing the index individuals within households will ascertain the risk of exposure for the contact participant. These data will be used to strengthen the precision of efficacy estimates. This ancillary observational study will assess the cofactors for infectiousness among index individuals whose close contacts are enrolled in COVID-19 prevention clinical trials. Additionally, this study will assess post-acute sequelae of SARS-CoV-2 infection in index individuals that are more than two weeks past their initial diagnosis.

NCT ID: NCT05074667 Completed - Type 2 Diabetes Clinical Trials

Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this pilot feasibility study is to provide continued CGM access to youth with type 2 diabetes and collect descriptive data about feasibility of use of CGM in youth with type 2 diabetes ages 4 years and older. From this study the investigators hope to learn if CGM use in youth with type 2 diabetes can be tolerated and sustained with good adherence and to describe blood glucose patterns in youth with type 2 diabetes. The primary aim will be to evaluate the feasibility of CGM start and continuation in youth with T2D and describe glucose metrics and patient reported outcomes (PROs). The investigators will pilot and refine a program to test the hypothesis that CGM start and continuation in youth with T2D is feasible and then evaluate glucose metrics and PROs.

NCT ID: NCT05074524 Completed - Opioid-use Disorder Clinical Trials

Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings

Start date: October 6, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.